Investors Press Releases Cardiol Therapeutics Appoints Bruce Hirsche and Peter Pekos to Board of Directors December 15, 2017 Cardiol Signs Letter of Intent with TecSalud and Nano4heart for the Development of Heart Failure Therapies November 17, 2017 Cardiol Therapeutics Closes $1,800,000 Non-Brokered Private Placement September 29, 2017 Cardiol Therapeutics Signs Exclusive Agreement With Dalton Pharma Services to Supply Pharmaceutical Cannabidiol June 14, 2017 Cardiol Therapeutics Appoints Graham Pockley, PhD to Scientific Advisory Board May 25, 2017 Cardiol Appoints Dr. Jonathan Howlett to Scientific Advisory Board May 09, 2017 Cardiol Therapeutics Appoints Dr. Guillermo Torre-Amione to Scientific Advisory Board April 25, 2017 Cardiol Therapeutics Closes $1,500,000 Non-Brokered Private Placement March 24, 2017 Cardiol Therapeutics Appoints Afsaneh Lavasanifar, PharmD, PhD to Scientific Advisory Board March 14, 2017 Cardiol Therapeutics Granted Exclusive Global License to Nanotechnology for Heart Failure, Cardiovascular, and Cardiopulmonary Disease January 20, 2017 Page 3 of 3«123
